| 2 | Argatroban Use in Pediatric Patients Supported by Paracorporeal Ventricular Assist Devices. (Tuttle MG, Yan K, Zhang J, Niebler RA) ASAIO J 2024 Mar 01;70(3):224-229 |
| 1 | Cloned antibodies from patients with HIT provide new clues to HIT pathogenesis. (Zhu W, Zheng Y, Yu M, Wu Y, Wei J, Zhou L, Fu G, Schneider N, Jones C, Irani M, Padmanabhan A, Aster R, Wang D, Wen R) Blood 2023 Mar 02;141(9):1060-1069 |
| 1 | Peripartum management of deep venous thrombosis in the context of antithrombin deficiency and May-Thurner syndrome. (Stevens-Haas CL, Livergood MC, Perez Botero J, McIntosh JJ) Blood Coagul Fibrinolysis 2023 Apr 01;34(3):211-214 |
| 1 | Anticoagulation in hospitalized patients with COVID-19. (Baumann Kreuziger L, Sholzberg M, Cushman M) Blood 2022 Aug 25;140(8):809-814 13 Citations |
| 1 | Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial. (Berger JS, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Cheng Y, McVerry BJ, Kim KS, Lopes RD, Atassi B, Berry S, Bochicchio G, de Oliveira Antunes M, Farkouh ME, Greenstein Y, Hade EM, Hudock K, Hyzy R, Khatri P, Kindzelski A, Kirwan BA, Baumann Kreuziger L, Lawler PR, Leifer E, Lopez-Sendon Moreno J, Lopez-Sendon J, Luther JF, Nigro Maia L, Quigley J, Sherwin R, Wahid L, Wilson J, Hochman JS, Neal MD, ACTIV-4a Investigators) JAMA 2022 Jan 18;327(3):227-236 89 Citations |
| 1 | Multicentre evaluation of 5B9, a monoclonal anti-PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology. (Pouplard C, Rollin J, Vayne C, Charuel N, Ahmadi Z, Alberio L, Azjenberg N, Althaus K, Bakchoul T, Chong B, Curtis BR, Faille D, Gomez FJ, Gresele P, Morel-Kopp MC, Mullier F, Nazy I, Smith JW, Greinacher A, Gruel Y) J Thromb Haemost 2022 Jan;20(1):252-259 5 Citations |
| 1 | Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial. (Spyropoulos AC, Goldin M, Giannis D, Diab W, Wang J, Khanijo S, Mignatti A, Gianos E, Cohen M, Sharifova G, Lund JM, Tafur A, Lewis PA, Cohoon KP, Rahman H, Sison CP, Lesser ML, Ochani K, Agrawal N, Hsia J, Anderson VE, Bonaca M, Halperin JL, Weitz JI, HEP-COVID Investigators) JAMA Intern Med 2021 Dec 01;181(12):1612-1620 298 Citations |
| 2 | Heparin Monitoring with an Anti-Xa Protocol Compared to Activated Clotting Time in Patients on Temporary Mechanical Circulatory Support. (Feih JT, Wallskog KE, Rinka JRG, Juul JJ, Rein L, Gaglianello N, Baumann Kreuziger LM, Joyce DL, Tawil JN) Ann Pharmacother 2022 May;56(5):513-523 5 Citations |
| 1 | Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. (ATTACC Investigators, ACTIV-4a Investigators, REMAP-CAP Investigators, Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR, Turgeon AF, Escobedo J, Huang DT, Bradbury CA, Houston BL, Kornblith LZ, Kumar A, Kahn SR, Cushman M, McQuilten Z, Slutsky AS, Kim KS, Gordon AC, Kirwan BA, Brooks MM, Higgins AM, Lewis RJ, Lorenzi E, Berry SM, Berry LR, Aday AW, Al-Beidh F, Annane D, Arabi YM, Aryal D, Baumann Kreuziger L, Beane A, Bhimani Z, Bihari S, Billett HH, Bond L, Bonten M, Brunkhorst F, Buxton M, Buzgau A, Castellucci LA, Chekuri S, Chen JT, Cheng AC, Chkhikvadze T, Coiffard B, Costantini TW, de Brouwer S, Derde LPG, Detry MA, Duggal A, Džavík V, Effron MB, Estcourt LJ, Everett BM, Fergusson DA, Fitzgerald M, Fowler RA, Galanaud JP, Galen BT, Gandotra S, García-Madrona S, Girard TD, Godoy LC, Goodman AL, Goossens H, Green C, Greenstein YY, Gross PL, Hamburg NM, Haniffa R, Hanna G, Hanna N, Hegde SM, Hendrickson CM, Hite RD, Hindenburg AA, Hope AA, Horowitz JM, Horvat CM, Hudock K, Hunt BJ, Husain M, Hyzy RC, Iyer VN, Jacobson JR, Jayakumar D, Keller NM, Khan A, Kim Y, Kindzelski AL, King AJ, Knudson MM, Kornblith AE, Krishnan V, Kutcher ME, Laffan MA, Lamontagne F, Le Gal G, Leeper CM, Leifer ES, Lim G, Lima FG, Linstrum K, Litton E, Lopez-Sendon J, Lopez-Sendon Moreno JL, Lother SA, Malhotra S, Marcos M, Saud Marinez A, Marshall JC, Marten N, Matthay MA, McAuley DF, McDonald EG, McGlothlin A, McGuinness SP, Middeldorp S, Montgomery SK, Moore SC, Morillo Guerrero R, Mouncey PR, Murthy S, Nair GB, Nair R, Nichol AD, Nunez-Garcia B, Pandey A, Park PK, Parke RL, Parker JC, Parnia S, Paul JD, Pérez González YS, Pompilio M, Prekker ME, Quigley JG, Rost NS, Rowan K, Santos FO, Santos M, Olombrada Santos M, Satterwhite L, Saunders CT, Schutgens REG, Seymour CW, Siegal DM, Silva DG Jr, Shankar-Hari M, Sheehan JP, Singhal AB, Solvason D, Stanworth SJ, Tritschler T, Turner AM, van Bentum-Puijk W, van de Veerdonk FL, van Diepen S, Vazquez-Grande G, Wahid L, Wareham V, Wells BJ, Widmer RJ, Wilson JG, Yuriditsky E, Zampieri FG, Angus DC, McArthur CJ, Webb SA, Farkouh ME, Hochman JS, Zarychanski R) N Engl J Med 2021 Aug 26;385(9):790-802 604 Citations |
| 1 | Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. (REMAP-CAP Investigators, ACTIV-4a Investigators, ATTACC Investigators, Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF, Kornblith LZ, Kahn SR, Marshall JC, Kim KS, Houston BL, Derde LPG, Cushman M, Tritschler T, Angus DC, Godoy LC, McQuilten Z, Kirwan BA, Farkouh ME, Brooks MM, Lewis RJ, Berry LR, Lorenzi E, Gordon AC, Ahuja T, Al-Beidh F, Annane D, Arabi YM, Aryal D, Baumann Kreuziger L, Beane A, Bhimani Z, Bihari S, Billett HH, Bond L, Bonten M, Brunkhorst F, Buxton M, Buzgau A, Castellucci LA, Chekuri S, Chen JT, Cheng AC, Chkhikvadze T, Coiffard B, Contreras A, Costantini TW, de Brouwer S, Detry MA, Duggal A, Džavík V, Effron MB, Eng HF, Escobedo J, Estcourt LJ, Everett BM, Fergusson DA, Fitzgerald M, Fowler RA, Froess JD, Fu Z, Galanaud JP, Galen BT, Gandotra S, Girard TD, Goodman AL, Goossens H, Green C, Greenstein YY, Gross PL, Haniffa R, Hegde SM, Hendrickson CM, Higgins AM, Hindenburg AA, Hope AA, Horowitz JM, Horvat CM, Huang DT, Hudock K, Hunt BJ, Husain M, Hyzy RC, Jacobson JR, Jayakumar D, Keller NM, Khan A, Kim Y, Kindzelski A, King AJ, Knudson MM, Kornblith AE, Kutcher ME, Laffan MA, Lamontagne F, Le Gal G, Leeper CM, Leifer ES, Lim G, Gallego Lima F, Linstrum K, Litton E, Lopez-Sendon J, Lother SA, Marten N, Saud Marinez A, Martinez M, Mateos Garcia E, Mavromichalis S, McAuley DF, McDonald EG, McGlothlin A, McGuinness SP, Middeldorp S, Montgomery SK, Mouncey PR, Murthy S, Nair GB, Nair R, Nichol AD, Nicolau JC, Nunez-Garcia B, Park JJ, Park PK, Parke RL, Parker JC, Parnia S, Paul JD, Pompilio M, Quigley JG, Rosenson RS, Rost NS, Rowan K, Santos FO, Santos M, Santos MO, Satterwhite L, Saunders CT, Schreiber J, Schutgens REG, Seymour CW, Siegal DM, Silva DG Jr, Singhal AB, Slutsky AS, Solvason D, Stanworth SJ, Turner AM, van Bentum-Puijk W, van de Veerdonk FL, van Diepen S, Vazquez-Grande G, Wahid L, Wareham V, Widmer RJ, Wilson JG, Yuriditsky E, Zhong Y, Berry SM, McArthur CJ, Neal MD, Hochman JS, Webb SA, Zarychanski R) N Engl J Med 2021 Aug 26;385(9):777-789 623 Citations |
| 1 | Heparin-mediated antibiotic delivery from an electrochemically-aligned collagen sheet. (Cheng OT, Stein AP, Babajanian E, Hoppe KR, Li S, Jung H, Abrol A, Akkus A, Younesi M, Altawallbeh G, Ghannoum MA, Bonfield T, Akkus O, Zender CA) Biomed Mater Eng 2021;32(3):159-170 1 Citation |
| 1 | Retrospective analysis of outcomes in patients with acute hypertriglyceridemic pancreatitis treated without therapeutic plasma exchange. (Hutchison B, Collins J, Makar RS, Dzik W) Transfusion 2021 Feb;61(2):537-545 11 Citations |
| 1 | North American Physician Practice Patterns in the Management of Anticoagulation in Pregnancy. (Cohen AJ, Boggio L, Billett HH, DeSancho MT, Gaddh M, Kouides P, Lim M, Nyak L, Rajan S, Rosovsky R, Streiff M, Wang TF, Baumann Kreuziger L) J Womens Health (Larchmt) 2021 Jun;30(6):829-836 3 Citations |
| 1 | Association of Heparin Dose, Route, Timing, and Duration With Heparin-Induced Thrombocytopenia. (Crow JR, Nam L, Chasler JE, Ong CS, Dane KE, Kickler T, Lawton J, Streiff MB, Alejo D, Canner JK, Schena S) Ann Thorac Surg 2021 Jul;112(1):32-37 6 Citations |
| 2 | Specific binding-induced modulation of the XCL1 metamorphic equilibrium. (Dishman AF, Peterson FC, Volkman BF) Biopolymers 2021 Oct;112(10):e23402 |
| 1 | A prospective, blinded study of a PF4-dependent assay for HIT diagnosis. (Samuelson Bannow B, Warad DM, Jones CG, Pechauer SM, Curtis BR, Bougie DW, Sharma R, Grill DE, Redman MW, Khalighi PR, Leger RR, Pruthi RK, Chen D, Sabath DE, Aster RH, Garcia DA, Padmanabhan A) Blood 2021 Feb 25;137(8):1082-1089 24 Citations |
| 1 | Too Much of a Good Thing? Cerebral Sinovenous Thrombosis Due to Excessive Milk Intake Associated Anemia. (Farias-Moeller R, Siddiqui S, Orr M, Mondok L) J Child Neurol 2020 Aug;35(9):585-590 3 Citations |
| 3 | Use of IV Immunoglobulin G in Heparin-Induced Thrombocytopenia Patients Is Not Associated With Increased Rates of Thrombosis: A Population-Based Study. (Dhakal B, Rein L, Szabo A, Padmanabhan A) Chest 2020 Sep;158(3):1172-1175 7 Citations |
| 1 | A practical approach to evaluating postoperative thrombocytopenia. (Skeith L, Baumann Kreuziger L, Crowther MA, Warkentin TE) Blood Adv 2020 Feb 25;4(4):776-783 21 Citations |
| 1 | Portal Vein Thrombosis After Total Pancreatectomy and Islet Autotransplant: Prophylaxis and Graft Impact. (Robbins AJ, Skube ME, Bellin MD, Dunn TB, Chapman SA, Berry KL, Lusczek E, Beilman GJ) Pancreas 2019;48(10):1329-1333 14 Citations |
| 1 | A Woman with Pancreatitis and Hypertriglyceridemia. (Farooq A, Treml A, Colón-Franco JM) Clin Chem 2019 Oct;65(10):1216-1218 |
| 1 | Regulatory T Cells Control PF4/Heparin Antibody Production in Mice. (Zheng Y, Zhu W, Haribhai D, Williams CB, Aster RH, Wen R, Wang D) J Immunol 2019 Oct 01;203(7):1786-1792 11 Citations |
| 1 | Commentary: Thromboprophylaxis after congenital cardiac surgery-Time for evidence-based guidelines. (Scott JP) J Thorac Cardiovasc Surg 2019 Oct;158(4):1207-1208 |
| 1 | Unfractionated heparin dosing requirements in the presence of inflammation during the first six months of life. (Heizer JW, Schardt TQ, Murphy ME, Branchford BR) Thromb Res 2019 May;177:17-22 2 Citations |
| 1 | Plasma exchange for heparin-induced thrombocytopenia in patients on extracorporeal circuits: A challenging case and a survey of the field. (Cho JH, Parilla M, Treml A, Wool GD) J Clin Apher 2019 Feb;34(1):64-72 10 Citations |
| 2 | Plasma Proteolytic Cascade Activation during Neonatal Cardiopulmonary Bypass Surgery. (Maroney SA, Peterson JA, Zwifelhofer W, Martinez ND, Yan K, Bercovitz RS, Woods RK, Mast AE) Thromb Haemost 2018 Sep;118(9):1545-1555 5 Citations |
| 1 | Heparin-protamine balance after neonatal cardiopulmonary bypass surgery. (Peterson JA, Maroney SA, Zwifelhofer W, Wood JP, Yan K, Bercovitz RS, Woods RK, Mast AE) J Thromb Haemost 2018 Oct;16(10):1973-1983 8 Citations |
| 2 | Impact of Anticoagulation and Circuit Technology on Complications During Extracorporeal Membrane Oxygenation. (Niebler RA, Parker H, Hoffman GM) ASAIO J 2019;65(3):270-276 28 Citations |
| 4 | Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study. (Dhakal B, Kreuziger LB, Rein L, Kleman A, Fraser R, Aster RH, Hari P, Padmanabhan A) Lancet Haematol 2018 May;5(5):e220-e231 65 Citations |
| 1 | Normal plasma IgG inhibits HIT antibody-mediated platelet activation: implications for therapeutic plasma exchange. (Jones CG, Pechauer SM, Curtis BR, Bougie DW, Aster RH, Padmanabhan A) Blood 2018 Feb 08;131(6):703-706 21 Citations |
| 2 | A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies. (Jones CG, Pechauer SM, Curtis BR, Bougie DW, Irani MS, Dhakal B, Pierce B, Aster RH, Padmanabhan A) Chest 2017 Oct;152(4):e77-e80 19 Citations |
| 1 | Bivalirudin versus heparin in patients undergoing percutaneous transcatheter aortic valve interventions: A systematic review and meta-analysis. (Villablanca PA, Al-Bawardy R, Mohananey D, Maraboto C, Weinreich M, Gupta T, Briceno DF, Ramakrishna H) J Interv Cardiol 2017 Dec;30(6):586-594 5 Citations |
| 1 | The Use of Eptifibatide Alone or in Combination With Heparin or Argatroban for Suspected Thrombosis in Patients With Left Ventricular Assist Devices. (Bitar A, Vijayakrishnan R, Lenneman A, Birks E, Massey T, Slaughter M, Abramov D) Artif Organs 2017 Dec;41(12):1092-1098 5 Citations |
| 4 | IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia. (Padmanabhan A, Jones CG, Pechauer SM, Curtis BR, Bougie DW, Irani MS, Bryant BJ, Alperin JB, Deloughery TG, Mulvey KP, Dhakal B, Wen R, Wang D, Aster RH) Chest 2017 Sep;152(3):478-485 88 Citations |
| 1 | Pulmonary embolism and in situ pulmonary artery thrombosis in paediatrics. A systematic review. (Rajpurkar M, Biss T, Amankwah EK, Martinez D, Williams S, Van Ommen CH, Goldenberg NA) Thromb Haemost 2017 Jun 02;117(6):1199-1207 48 Citations |
| 1 | Estimating glycosaminoglycan-protein interaction affinity: water dominates the specific antithrombin-heparin interaction. (Sarkar A, Yu W, Desai UR, MacKerell AD, Mosier PD) Glycobiology 2016 Oct;26(10):1041-1047 16 Citations |
| 1 | Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins. (Wood JP, Baumann Kreuziger LM, Desai UR, Mast AE) Br J Haematol 2016 Oct;175(1):123-32 3 Citations |
| 2 | A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis. (Padmanabhan A, Jones CG, Curtis BR, Bougie DW, Sullivan MJ, Peswani N, McFarland JG, Eastwood D, Wang D, Aster RH) Chest 2016 Sep;150(3):506-15 77 Citations |
| 2 | Examination of Glycosaminoglycan Binding Sites on the XCL1 Dimer. (Fox JC, Tyler RC, Peterson FC, Dyer DP, Zhang F, Linhardt RJ, Handel TM, Volkman BF) Biochemistry 2016 Mar 01;55(8):1214-25 15 Citations |
| 7 | A Pilot Study of Antithrombin Replacement Prior to Cardiopulmonary Bypass in Neonates. (Niebler RA, Woods KJ, Murkowski K, Ghanayem NS, Hoffman G, Mitchell ME, Punzalan RC, Scott JP, Simpson P, Tweddell JS) Artif Organs 2016 Jan;40(1):80-5 9 Citations |
| 1 | The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization. (Dyer DP, Salanga CL, Volkman BF, Kawamura T, Handel TM) Glycobiology 2016 Mar;26(3):312-26 82 Citations |
| 1 | Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions. (Joseph PR, Mosier PD, Desai UR, Rajarathnam K) Biochem J 2015 Nov 15;472(1):121-33 88 Citations |
| 2 | Engineering Metamorphic Chemokine Lymphotactin/XCL1 into the GAG-Binding, HIV-Inhibitory Dimer Conformation. (Fox JC, Tyler RC, Guzzo C, Tuinstra RL, Peterson FC, Lusso P, Volkman BF) ACS Chem Biol 2015 Nov 20;10(11):2580-8 22 Citations |
| 1 | A modified PF4-dependent, CD62p expression assay selectively detects serotonin-releasing antibodies in patients suspected of HIT. (Padmanabhan A, Jones CG, Bougie DW, Curtis BR, McFarland JG, Wang D, Aster RH) Thromb Haemost 2015 Nov 25;114(6):1322-3 23 Citations |
| 1 | Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery. (Yamamoto T, Wolf HG, Sinzobahamvya N, Asfour B, Hraska V, Schindler E) Thorac Cardiovasc Surg 2015 Aug;63(5):397-403 18 Citations |
| 1 | NHLBI state of the science symposium in therapeutic apheresis: Knowledge gaps and research opportunities in the area of hematology-oncology. (Karafin MS, Sachais BS, Connelly-Smith L, Field JJ, Linenberger ML, Padmanabhan A) J Clin Apher 2016 Feb;31(1):38-47 6 Citations |
| 2 | Critical role of CD4 T cells in PF4/heparin antibody production in mice. (Zheng Y, Yu M, Padmanabhan A, Aster RH, Yuan L, Wen R, Wang D) Blood 2015 Mar 12;125(11):1826-9 24 Citations |
| 1 | Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily. (Fox JC, Nakayama T, Tyler RC, Sander TL, Yoshie O, Volkman BF) Cytokine 2015 Feb;71(2):302-11 45 Citations |
| 2 | Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis. (Padmanabhan A, Jones CG, Bougie DW, Curtis BR, McFarland JG, Wang D, Aster RH) Blood 2015 Jan 01;125(1):155-61 68 Citations |
| 1 | Total pancreatectomy with islet autotransplantation: summary of a National Institute of Diabetes and Digestive and Kidney diseases workshop. (Bellin MD, Gelrud A, Arreaza-Rubin G, Dunn TB, Humar A, Morgan KA, Naziruddin B, Rastellini C, Rickels MR, Schwarzenberg SJ, Andersen DK) Pancreas 2014 Nov;43(8):1163-71 41 Citations |
| 1 | Designing "high-affinity, high-specificity" glycosaminoglycan sequences through computerized modeling. (Sankaranarayanan NV, Sarkar A, Desai UR, Mosier PD) Methods Mol Biol 2015;1229:289-314 16 Citations |
| 5 | B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia. (Zheng Y, Wang AW, Yu M, Padmanabhan A, Tourdot BE, Newman DK, White GC, Aster RH, Wen R, Wang D) Blood 2014 Feb 06;123(6):931-4 42 Citations |
| 4 | Critical role for mouse marginal zone B cells in PF4/heparin antibody production. (Zheng Y, Yu M, Podd A, Yuan L, Newman DK, Wen R, Arepally G, Wang D) Blood 2013 Apr 25;121(17):3484-92 40 Citations |
| 1 | Protamine-induced immune thrombocytopenia. (Singla A, Sullivan MJ, Lee G, Bartholomew J, Kapadia S, Aster RH, Curtis BR) Transfusion 2013 Oct;53(10):2158-63 20 Citations |
| 2 | Heparin rescues factor V Leiden-associated placental failure independent of anticoagulation in a murine high-risk pregnancy model. (An J, Waitara MS, Bordas M, Arumugam V, Hoffmann RG, Petrich BG, Sinha U, North PE, Sood R) Blood 2013 Mar 14;121(11):2127-34 17 Citations |
| 1 | On the specificity of heparin/heparan sulfate binding to proteins. Anion-binding sites on antithrombin and thrombin are fundamentally different. (Mosier PD, Krishnasamy C, Kellogg GE, Desai UR) PLoS One 2012;7(11):e48632 44 Citations |
| 2 | Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus. (Ziarek JJ, Veldkamp CT, Zhang F, Murray NJ, Kartz GA, Liang X, Su J, Baker JE, Linhardt RJ, Volkman BF) J Biol Chem 2013 Jan 04;288(1):737-46 72 Citations |
| 1 | Designing allosteric regulators of thrombin. Monosulfated benzofuran dimers selectively interact with Arg173 of exosite 2 to induce inhibition. (Abdel Aziz MH, Sidhu PS, Liang A, Kim JY, Mosier PD, Zhou Q, Farrell DH, Desai UR) J Med Chem 2012 Aug 09;55(15):6888-97 35 Citations |
| 1 | Improving the specificity of the PF4 ELISA in diagnosing heparin-induced thrombocytopenia. (McFarland J, Lochowicz A, Aster R, Chappell B, Curtis B) Am J Hematol 2012 Aug;87(8):776-81 26 Citations |
| 1 | Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. (Thu MS, Bryant LH, Coppola T, Jordan EK, Budde MD, Lewis BK, Chaudhry A, Ren J, Varma NR, Arbab AS, Frank JA) Nat Med 2012 Feb 26;18(3):463-7 179 Citations |
| 3 | Antithrombin replacement during extracorporeal membrane oxygenation. (Niebler RA, Christensen M, Berens R, Wellner H, Mikhailov T, Tweddell JS) Artif Organs 2011 Nov;35(11):1024-8 95 Citations |
| 1 | Strategies for the prevention of central venous catheter infections: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. (Huang EY, Chen C, Abdullah F, Aspelund G, Barnhart DC, Calkins CM, Cowles RA, Downard CD, Goldin AB, Lee SL, St Peter SD, Arca MJ, 2011 American Pediatric Surgical Association Outcomes and Clinical Trials Committee) J Pediatr Surg 2011 Oct;46(10):2000-11 64 Citations |
| 4 | Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling. (Gao C, Boylan B, Fang J, Wilcox DA, Newman DK, Newman PJ) Blood 2011 May 05;117(18):4946-52 109 Citations |
| 1 | Septic renal vein thrombosis complicated by septic pulmonary embolism. (Iqbal FM, Sadat K, Spear JB) Compr Ther 2010;36:14-7 2 Citations |
| 1 | A patient with 'spontaneous' heparin-induced thrombocytopenia and thrombosis after undergoing knee replacement. (Mallik A, Carlson KB, DeSancho MT) Blood Coagul Fibrinolysis 2011 Jan;22(1):73-5 23 Citations |
| 2 | Lipid-induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL. (Kashyap SR, Ioachimescu AG, Gornik HL, Gopan T, Davidson MB, Makdissi A, Major J, Febbraio M, Silverstein RL) Obesity (Silver Spring) 2009 Dec;17(12):2142-8 51 Citations |
| 2 | Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain. (Gao C, Boylan B, Bougie D, Gill JC, Birenbaum J, Newman DK, Aster RH, Newman PJ) J Clin Invest 2009 Mar;119(3):504-11 55 Citations |
| 1 | Differential increase of mitochondrial matrix volume by sevoflurane in isolated cardiac mitochondria. (Riess ML, Costa AD, Carlson R Jr, Garlid KD, Heinen A, Stowe DF) Anesth Analg 2008 Apr;106(4):1049-55, table of contents 18 Citations |
| 1 | Prevalence of heparin-dependent platelet antibodies in children after cardiopulmonary bypass. (Hanson SJ, Punzalan RC, Ghanayem N, Havens P) Pediatr Crit Care Med 2007 Jul;8(4):358-61 12 Citations |
| 1 | Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: A metaanalysis. (King CS, Holley AB, Jackson JL, Shorr AF, Moores LK) Chest 2007 Feb;131(2):507-16 102 Citations |
| 1 | Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s). (Raghuraman A, Mosier PD, Desai UR) J Med Chem 2006 Jun 15;49(12):3553-62 65 Citations |
| 1 | 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells. (Göőz M, Göőz P, Luttrell LM, Raymond JR) J Biol Chem 2006 Jul 28;281(30):21004-21012 90 Citations |
| 1 | Effect of heparin on viologen-stimulated enzymatic NADH depletion. (Zielonka J, Rybak M, Celińska J, Adamus J, Marcinek A, Gebicki J) Chem Res Toxicol 2006 May;19(5):668-73 11 Citations |
| 1 | A murine model of deep vein thrombosis: characterization and validation in transgenic mice. (Cooley BC, Szema L, Chen CY, Schwab JP, Schmeling G) Thromb Haemost 2005 Sep;94(3):498-503 38 Citations |
| 2 | A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. (Garland JS, Alex CP, Henrickson KJ, McAuliffe TL, Maki DG) Pediatrics 2005 Aug;116(2):e198-205 136 Citations |
| 1 | Provider preferences for DVT prophylaxis. (Holley AB, Moores LK, Jackson JL) Thromb Res 2006;117(5):563-8 11 Citations |
| 2 | The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin. (Veldkamp CT, Peterson FC, Pelzek AJ, Volkman BF) Protein Sci 2005 Apr;14(4):1071-81 153 Citations |
| 1 | A prothrombotic phenotype in the Copenhagen rat strain. (Cooley BC, Chen CY, Friedman KD, Datta Y) Thromb Res 2005;115(1-2):153-7 1 Citation |
| 1 | Late bleeding from right internal mammary artery after HeartMate left ventricular assist device implantation. (Kohmoto T, Oz MC, Naka Y) Ann Thorac Surg 2004 Aug;78(2):689-91 9 Citations |
| 2 | Identification and characterization of a glycosaminoglycan recognition element of the C chemokine lymphotactin. (Peterson FC, Elgin ES, Nelson TJ, Zhang F, Hoeger TJ, Linhardt RJ, Volkman BF) J Biol Chem 2004 Mar 26;279(13):12598-604 71 Citations |
| 1 | Progressive exercise-induced asthma in a 38-year-old man. (Gimenez LM, Zacharisen MC, Nordness ME) Ann Allergy Asthma Immunol 2003 Aug;91(2):141-7 1 Citation |
| 1 | Excessive argatroban anticoagulation for heparin-induced thrombocytopenia. (Reichert MG, MacGregor DA, Kincaid EH, Dolinski SY) Ann Pharmacother 2003 May;37(5):652-4 73 Citations |
| 2 | Infiltration anesthetic lidocaine inhibits cancer cell invasion by modulating ectodomain shedding of heparin-binding epidermal growth factor-like growth factor (HB-EGF). (Mammoto T, Higashiyama S, Mukai M, Mammoto A, Ayaki M, Mashimo T, Hayashi Y, Kishi Y, Nakamura H, Akedo H) J Cell Physiol 2002 Sep;192(3):351-8 50 Citations |
| 1 | Successful treatment of an acute flare of steroid-resistant Crohn's colitis during pregnancy with unfractionated heparin. (Prajapati DN, Newcomer JR, Emmons J, Abu-Hajir M, Binion DG) Inflamm Bowel Dis 2002 May;8(3):192-5 25 Citations |
| 1 | Cell surface glypicans are low-affinity endostatin receptors. (Karumanchi SA, Jha V, Ramchandran R, Karihaloo A, Tsiokas L, Chan B, Dhanabal M, Hanai JI, Venkataraman G, Shriver Z, Keiser N, Kalluri R, Zeng H, Mukhopadhyay D, Chen RL, Lander AD, Hagihara K, Yamaguchi Y, Sasisekharan R, Cantley L, Sukhatme VP) Mol Cell 2001 Apr;7(4):811-22 274 Citations |
| 1 | Fatal thrombosis associated with a hemi-fontan procedure, heparin-protamine reversal, and aprotinin. (Heindel SW, Mill MR, Freid EB, Valley RD, White GC 2nd, Norfleet EA) Anesthesiology 2001 Feb;94(2):369-71 27 Citations |
| 1 | Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial. (Henrickson KJ, Axtell RA, Hoover SM, Kuhn SM, Pritchett J, Kehl SC, Klein JP) J Clin Oncol 2000 Mar;18(6):1269-78 213 Citations |
| 1 | Acute cocaine exposure up-regulates complement expression in rabbit heart. (Tanhehco EJ, Yasojima K, McGeer PL, Lucchesi BR) J Pharmacol Exp Ther 2000 Jan;292(1):201-8 7 Citations |
| 1 | The prevention and management of complications after stroke. (McGuire JR, Harvey RL) Phys Med Rehabil Clin N Am 1999 Nov;10(4):857-74, ix 24 Citations |
| 1 | Ex vivo reversal of heparin-mediated cardioprotection by heparinase after ischemia and reperfusion. (Kilgore KS, Tanhehco EJ, Naylor KB, Lucchesi BR) J Pharmacol Exp Ther 1999 Sep;290(3):1041-7 19 Citations |
| 1 | Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1. (Pijuan-Thompson V, Grammer JR, Stewart J, Silverstein RL, Pearce SF, Tuszynski GP, Murphy-Ullrich JE, Gladson CL) Exp Cell Res 1999 May 25;249(1):86-101 37 Citations |
| 1 | Selective thrombolysis of central retinal artery occlusion without long-term systemic heparinization. (Wirostko WJ, Pulido JS, Hendrix LE) Surg Neurol 1998 Nov;50(5):408-10 15 Citations |
| 1 | Effect of direct thrombin inhibition with Bivalirudin (Hirulog) on restenosis after coronary angioplasty. (Burchenal JE, Marks DS, Tift Mann J, Schweiger MJ, Rothman MT, Ganz P, Adelman B, Bittl JA) Am J Cardiol 1998 Aug 15;82(4):511-5 29 Citations |
| 1 | Anticoagulation therapy in patients with venous thromboembolic disease. (Whittle J, Johnson P, Localio AR) J Gen Intern Med 1998 Jun;13(6):373-8 7 Citations |
| 1 | Type 2M:Milwaukee-1 von Willebrand disease: an in-frame deletion in the Cys509-Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets. (Mancuso DJ, Kroner PA, Christopherson PA, Vokac EA, Gill JC, Montgomery RR) Blood 1996 Oct 01;88(7):2559-68 59 Citations |
| 1 | Protamine induces endothelium-dependent vasodilatation of the pulmonary artery. (Evora PR, Pearson PJ, Schaff HV) Ann Thorac Surg 1995 Aug;60(2):405-10 28 Citations |
| 1 | Hemagglutination and proteoglycan binding by the Lyme disease spirochete, Borrelia burgdorferi. (Leong JM, Morrissey PE, Ortega-Barria E, Pereira ME, Coburn J) Infect Immun 1995 Mar;63(3):874-83 78 Citations |
| 1 | Protein kinase A induces phosphorylation of the human 5-HT1A receptor and augments its desensitization by protein kinase C in CHO-K1 cells. (Raymond JR, Olsen CL) Biochemistry 1994 Sep 20;33(37):11264-9 24 Citations |
| 1 | Internalization of fibroblast growth factor receptor is inhibited by a point mutation at tyrosine 766. (Sorokin A, Mohammadi M, Huang J, Schlessinger J) J Biol Chem 1994 Jun 24;269(25):17056-61 106 Citations |
| 1 | Prevention of recurrent central venous catheter infections with a novel flush solution in a patient on long-term hemodialysis. (Sheth KJ, Henrickson KJ) Pediatr Nephrol 1993 Aug;7(4):506 2 Citations |
| 1 | Hydrophobic affinity chromatography of human thrombin. (Lundblad RL, Tsai J, Wu HF, Jenzano JW, White GC 2nd, Connolly TM) Arch Biochem Biophys 1993 Apr;302(1):109-12 4 Citations |
| 1 | Modification of central venous catheter flush solution improves in vitro antimicrobial activity. (Henrickson KJ, Dunne WM Jr) J Infect Dis 1992 Oct;166(4):944-6 17 Citations |
| 1 | Protamine releases endothelium-derived relaxing factor from systemic arteries. A possible mechanism of hypotension during heparin neutralization. (Pearson PJ, Evora PR, Ayrancioglu K, Schaff HV) Circulation 1992 Jul;86(1):289-94 60 Citations |
| 1 | The de-endothelialized rat carotid arterial graft: a versatile experimental model for the investigation of arterial thrombosis. (Cooley BC, Li X, Dzwierzynski W, Gruel SM, Hall RL, Wright RR, O'Brien EM, Fagan D, Hanel DP, Gould JS) Thromb Res 1992 Jul 01;67(1):1-14 20 Citations |
| 2 | Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. (Schwartz C, Henrickson KJ, Roghmann K, Powell K) J Clin Oncol 1990 Sep;8(9):1591-7 186 Citations |
| 1 | Low incidence of thrombocytopenia with porcine mucosal heparin. A prospective multicenter study. (Rao AK, White GC, Sherman L, Colman R, Lan G, Ball AP) Arch Intern Med 1989 Jun;149(6):1285-8 30 Citations |
| 1 | Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity. (Owen J, Friedman KD, Grossman BA, Wilkins C, Berke AD, Powers ER) Blood 1988 Aug;72(2):616-20 206 Citations |
| 2 | A dilute solution of vancomycin and heparin retains antibacterial and anticoagulant activities. (Henrickson KJ, Powell KR, Schwartz CL) J Infect Dis 1988 Mar;157(3):600-1 29 Citations |
| 2 | Bilateral adrenal hemorrhage associated with heparin-induced thrombocytopenia. (Findling JW, Korducki JM, Lahiri PK, Miller DD, Raff H) Wis Med J 1987 Mar;86(3):27-9 24 Citations |
| 1 | Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein. (Silverstein RL, Leung LL, Harpel PC, Nachman RL) J Clin Invest 1985 Jun;75(6):2065-73 83 Citations |
| 1 | Severe homozygous protein C deficiency. (Sills RH, Marlar RA, Montgomery RR, Deshpande GN, Humbert JR) J Pediatr 1984 Sep;105(3):409-13 104 Citations |
| 1 | Characterization of the interaction between chymotrypsin and heparin. (Twining SS, Brecher AS) Can J Biochem 1977 Feb;55(2):134-9 1 Citation |
| 1 | [Demonstration of an antiheparin factor in the healthy and arteriosclerotic blood vessel wall]. (HOFFMEISTER K, PERLICK E) Thromb Diath Haemorrh 1961 Sep 01;6:365-70 |
